IESE (España)
-
El Instituto Mexicano del Seguro Social hacia la desconcentración de sus proveedores de servicios de salud
Jané E.; Ribera, JaumeCase P-1044Service and Operations ManagementEl Instituto Mexicano del Seguro Social (IMSS), una organización altamente centralizada y jerárquica, comenzó hace tres años un proceso de devolución de sus unidades de servicio, agrupadas en Areas Médicas de Gestión Desconcentrada (AMGD). El proceso era lento hasta que se diseñó un proyecto para crear las herramientas necesarias para administrarlo bajo las nuevas condiciones de autonomía. El Dr. Martín es el jefe de una de estas AMGD. El y sus ...Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
The Mexican Social Security Institute - Towards deconcentration of health service providers
Jané E.; Ribera, JaumeCase P-1044-EService and Operations ManagementThree years ago, the Mexican Social Security Institute (IMSS), a highly centralized and hierarchical organization, started to devolve powers to its service units, grouped in decentrally managed medical areas (AMGDs). It was a slow process until a project was set up to create the necessary tools to administer the new decentralized system. Dr. Martín is the head of one of the new medical areas. He and his bosses have made the necessary changes to ...Starting at €8.20
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20